Taken together, our data reveal an unforeseen biological interaction between GR-regulated transcription and EZH2-mediated chromatin remodeling, which suggest potential new avenues for clinical investigation in patients with therapy resistant NHL. This evidence concerns the gene NR3C1 and non-Hodgkin lymphoma.